Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Special Reports
Special Reports
The top 10 drug patent expirations of 2023
The Fierce Pharma team didn't want AbbVie's Humira to have the entire patent-cliff spotlight this year, so we're presenting this special report on that drug and nine others.
Fraiser Kansteiner
,
Eric Sagonowsky
,
Zoey Becker
,
Kevin Dunleavy
,
Angus Liu
Mar 13, 2023 3:00am
Top 10 most anticipated drug launches of 2023
Feb 6, 2023 3:00am
The top 10 biopharma M&A deals of 2022
Jan 30, 2023 3:00am
2022 drug approvals: Biopharma delivered 37 new drugs
Jan 3, 2023 3:00am
2022's Fiercest Women in Life Sciences
Nov 14, 2022 3:00am
The most productive biopharma workforces of 2021
Sep 26, 2022 3:00am
